Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Changes in Stockholders' Equity

v3.24.3
Condensed Consolidated Statements of Changes in Stockholders' Equity - USD ($)
Total
Common Stock
Additional Paid In Capital
Treasury Stock
Accumulated Deficit
Total The Joint Corp. stockholders' equity
Non-controlling interest
Balance, beginning common stock (in shares) at Dec. 31, 2022   14,560,353          
Balance, beginning at Dec. 31, 2022 $ 32,587,843 $ 14,560 $ 45,558,305 $ (856,642) $ (12,153,380) $ 32,562,843 $ 25,000
Balance, beginning treasury stock (in shares) at Dec. 31, 2022       31,866      
Stockholders' Equity [Roll Forward]              
Stock-based compensation expense 266,210   266,210     266,210  
Issuance of restricted stock, net of forfeitures (in shares)   95,386          
Issuance of restricted stock, net of forfeitures 0 $ 95 (95)     0  
Exercise of stock options (in shares)   15,621          
Exercise of stock options 138,457 $ 16 138,441     138,457  
Purchases of treasury stock under employee stock plans (in shares)       169      
Purchases of treasury stock under employee stock plans (2,637)     $ (2,637)   (2,637)  
Net income (loss) 2,326,164       2,326,164 2,326,164  
Balance, ending common stock (in shares) at Mar. 31, 2023   14,671,360          
Balance, ending at Mar. 31, 2023 35,316,037 $ 14,671 45,962,861 $ (859,279) (9,827,216) 35,291,037 25,000
Balance, ending treasury stock (in shares) at Mar. 31, 2023       32,035      
Balance, beginning common stock (in shares) at Dec. 31, 2022   14,560,353          
Balance, beginning at Dec. 31, 2022 32,587,843 $ 14,560 45,558,305 $ (856,642) (12,153,380) 32,562,843 25,000
Balance, beginning treasury stock (in shares) at Dec. 31, 2022       31,866      
Stockholders' Equity [Roll Forward]              
Net income (loss) 1,289,402            
Balance, ending common stock (in shares) at Sep. 30, 2023   14,786,411          
Balance, ending at Sep. 30, 2023 35,285,095 $ 14,786 46,969,761 $ (860,474) (10,863,978) 35,260,095 25,000
Balance, ending treasury stock (in shares) at Sep. 30, 2023       32,124      
Balance, beginning common stock (in shares) at Mar. 31, 2023   14,671,360          
Balance, beginning at Mar. 31, 2023 35,316,037 $ 14,671 45,962,861 $ (859,279) (9,827,216) 35,291,037 25,000
Balance, beginning treasury stock (in shares) at Mar. 31, 2023       32,035      
Stockholders' Equity [Roll Forward]              
Stock-based compensation expense 417,017   417,017     417,017  
Issuance of restricted stock, net of forfeitures (in shares)   91,158          
Issuance of restricted stock, net of forfeitures 0 $ 91 (91)     0  
Exercise of stock options (in shares)   10,002          
Exercise of stock options 63,929 $ 10 63,919     63,929  
Net income (loss) (320,489)       (320,489) (320,489)  
Balance, ending common stock (in shares) at Jun. 30, 2023   14,772,520          
Balance, ending at Jun. 30, 2023 35,476,494 $ 14,772 46,443,706 $ (859,279) (10,147,705) 35,451,494 25,000
Balance, ending treasury stock (in shares) at Jun. 30, 2023       32,035      
Stockholders' Equity [Roll Forward]              
Stock-based compensation expense 526,069   526,069     526,069  
Issuance of restricted stock, net of forfeitures (in shares)   13,891          
Issuance of restricted stock, net of forfeitures 0 $ 14 (14)     0  
Exercise of stock options (in shares)   0          
Exercise of stock options 0 $ 0 0     0  
Purchases of treasury stock under employee stock plans (in shares)       89      
Purchases of treasury stock under employee stock plans (1,195)     $ (1,195)   (1,195)  
Net income (loss) (716,273)       (716,273) (716,273)  
Balance, ending common stock (in shares) at Sep. 30, 2023   14,786,411          
Balance, ending at Sep. 30, 2023 $ 35,285,095 $ 14,786 46,969,761 $ (860,474) (10,863,978) 35,260,095 25,000
Balance, ending treasury stock (in shares) at Sep. 30, 2023       32,124      
Balance, beginning common stock (in shares) at Dec. 31, 2023 14,751,633 14,783,757          
Balance, beginning at Dec. 31, 2023 $ 24,771,882 $ 14,783 47,498,151 $ (860,475) (21,905,577) 24,746,882 25,000
Balance, beginning treasury stock (in shares) at Dec. 31, 2023 32,124     32,124      
Stockholders' Equity [Roll Forward]              
Stock-based compensation expense $ 493,395   493,395     493,395  
Issuance of restricted stock, net of forfeitures (in shares)   184,790          
Issuance of restricted stock, net of forfeitures 0 $ 184 (184)     0  
Exercise of stock options (in shares)   0          
Exercise of stock options 0 $ 0 0     0  
Purchases of treasury stock under employee stock plans (in shares)       707      
Purchases of treasury stock under employee stock plans (6,562)     $ (6,562)   (6,562)  
Net income (loss) 946,979       946,979 946,979  
Balance, ending common stock (in shares) at Mar. 31, 2024   14,968,547          
Balance, ending at Mar. 31, 2024 $ 26,205,694 $ 14,967 47,991,362 $ (867,037) (20,958,598) 26,180,694 25,000
Balance, ending treasury stock (in shares) at Mar. 31, 2024       32,831      
Balance, beginning common stock (in shares) at Dec. 31, 2023 14,751,633 14,783,757          
Balance, beginning at Dec. 31, 2023 $ 24,771,882 $ 14,783 47,498,151 $ (860,475) (21,905,577) 24,746,882 25,000
Balance, beginning treasury stock (in shares) at Dec. 31, 2023 32,124     32,124      
Stockholders' Equity [Roll Forward]              
Net income (loss) $ (5,814,558)            
Balance, ending common stock (in shares) at Sep. 30, 2024 14,958,447 14,991,462          
Balance, ending at Sep. 30, 2024 $ 20,475,549 $ 14,991 49,025,751 $ (870,058) (27,720,135) 20,450,549 25,000
Balance, ending treasury stock (in shares) at Sep. 30, 2024 33,015     33,015      
Balance, beginning common stock (in shares) at Mar. 31, 2024   14,968,547          
Balance, beginning at Mar. 31, 2024 $ 26,205,694 $ 14,967 47,991,362 $ (867,037) (20,958,598) 26,180,694 25,000
Balance, beginning treasury stock (in shares) at Mar. 31, 2024       32,831      
Stockholders' Equity [Roll Forward]              
Stock-based compensation expense 552,065   552,065     552,065  
Issuance of restricted stock, net of forfeitures (in shares)   21,905          
Issuance of restricted stock, net of forfeitures 0 $ 23 (23)     0  
Exercise of stock options (in shares)   6,335          
Exercise of stock options 52,098 $ 6 52,092     52,098  
Purchases of treasury stock under employee stock plans (in shares)       184      
Purchases of treasury stock under employee stock plans (3,021)     $ (3,021)   (3,021)  
Net income (loss) (3,596,398)       (3,596,398) (3,596,398)  
Balance, ending common stock (in shares) at Jun. 30, 2024   14,996,787          
Balance, ending at Jun. 30, 2024 23,210,438 $ 14,996 48,595,496 $ (870,058) (24,554,996) 23,185,438 25,000
Balance, ending treasury stock (in shares) at Jun. 30, 2024       33,015      
Stockholders' Equity [Roll Forward]              
Stock-based compensation expense 430,250   430,250     430,250  
Issuance of restricted stock, net of forfeitures (in shares)   (5,325)          
Issuance of restricted stock, net of forfeitures 0 $ (5) 5     0  
Exercise of stock options (in shares)   0          
Exercise of stock options 0 $ 0 0     0  
Purchases of treasury stock under employee stock plans 0         0  
Net income (loss) $ (3,165,139)       (3,165,139) (3,165,139)  
Balance, ending common stock (in shares) at Sep. 30, 2024 14,958,447 14,991,462          
Balance, ending at Sep. 30, 2024 $ 20,475,549 $ 14,991 $ 49,025,751 $ (870,058) $ (27,720,135) $ 20,450,549 $ 25,000
Balance, ending treasury stock (in shares) at Sep. 30, 2024 33,015     33,015